Use of beta blockers in patients with asthma and chronic obstructive pulmonary disease

Introduction. Beta blockers play an essential role in the treatment of cardiovascular diseases, but also various other endocrinological, gastroenterological, ophthalmological and neurological disorders. The most important effects beta are a reduction myocardial oxygen consumption inhibition renin secretion. divided into three generations according to their selectivity - non-selective, cardioselective vasodilating blockers. obstructive pulmonary diseases. Patients with diseases significantly more likely develop compared general population, largely due common risk factors such as smoking, systemic inflammation, age, genetic predisposition. use nonselective carries great for patients while can be used extensively. Reversible airway obstruction is predominantly present asthma, so that adverse on airways pronounced asthma chronic disease. Conclusion. In both disease, highly bisoprolol nebivolol preferred. requires caution possibility bronchial obstruction, disease they somewhat safer. must closely monitored by physician, special attention focused clinical signs wheezing, shortness breath, prolonged expiration.